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We i~vesti~f~d the c&acting sequences involve m the expression of the human Adolph C gene by transient mnsf~t~ons into b~man neuroblas- 
toma cells (SKNBE). We demonstrate that 420 bp of the Y-flanking DNA dimct at high efficiency the transcription of the CAT reporter gene. 
A deletion between -420 bp and - 164 bp causes a 60% decrease ofCAT activity. Gel shift and DNase I footprmtmg analyses revealed four protected 
elements: A, B, C and D. Competition analyses indicate that Spl or factors sharing a similar sequence specificity bind to elements A and B, but 
not to elements C and D. Sequence analysts hows a half palindromic ERE motrf(GGTCA), in elements B and D. Region D binds a transactivatmg 
factor which appears also essential to stabtlize the initiation complex. 
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Three distinct types of mammalian fructose- 1 ,6-bis- 
phosphate aldolase have been characterized by a variety 
of structural, biochemical and immunological methods 
[l]. These closely related isoenzymes, designated al- 
dolase A, B and C, are expressed in a tissue-specific 
fashion and are regulated during ontogenesis and 
cancerogenesis [2,3]. Three genes, A, B and C, locaiized 
on chromosomes 16% 9 and 17, respectively, encode for 
the three ~so~~z~mes (ih,S,@ We and others have eIoned 
and sequenced the human genes and cDNAs for the 
three aldolases [7--l 7]. 
Aldolase C is eharaGteristic of brain, where it is 
mainly localized in neurons and astroghal cells fl8.19]. 
The protein sequence of aldolase C has been deduced 
from the nucleotide sequence of mouse and rat comple- 
mentary cDNA clones [20,21] and from human and rat 
genomic clones [13,14,17,22]. The 5’ non-coding region 
has been analyzed in rat and man. Multiple start sites 
of transcription have been reported in rat f22], and one 
major start site has been described in man ]17]. 
In this paper we report the analysis of the ~~ornot~r 
region performed by ~~a~s~~~~* of fusion constructs 
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with a reporter gene into human neuronaf (SKNBE) cefl 
line and the identification of the bus-elements involved 
in the regulation of the human aldoias~ C gene expres- 
sion 
2. MATERIALS AND METHODS 
2. I.. Phwtid construction 
The aldolase C promoter region was excused from the gene as an 
XbaIlPsfI fragment. spanning from -1190 bp to +20 relative to the 
major transc~pt~onaI start site fI7], and cloned into the Ml3 rap19 
vector. The deletions were made by cuttmg the Y-end with X&rI and 
subsequently digesting with ExQIII m&ease (Boehringer Ma~n~e~m) 
@3]. The digested fragments were flush-ended by Klenow poiymerase 
and hgated into the Mi3 mp19 vector. The deleted fragments were 
checked by sequencing wtth the chain te~~nat~on method 124], excised 
from the vector with the appropriate res~~~ct~on enzyme, and then 
cloned m SmaIlPsrI sites upstream from the CAT reporter gene in the 
pEMBL-&CAT expression vector [25]. Chrmeric aldolase C-CAT 
plasmids were purified on a cesium chloride gradient. 
22. Cell culture, truxrrent trunsfections and CAT assays 
Human neuroblastoma (SKNBE) cultured in DMEM plus 10% 
fetalcalf serum (IGNI Flow) were plated at a density of about 250,000 
cells per 60 mm Fetrt dish 16 h before transfection. DNA transfections 
were carried out by the caicium phosphate precipitation method [26]. 
Cultures were co~r~~sfec~ed with 10 gg of test plasmrd and 1 pg of a 
vector carrying the luciferase gene under the control of an SV40 
e~ha~~rl~s promoter element f2’7j as internal standard for transfec- 
tion ef&iency. 2.5 h after transfecfion, SKNBE cells were exposed to 
15% glycerol in HYPES-buffered saline solution for I mm and then 
m-fed with growth medmm. Cell extracts were prepared 32 h after 
transfeection by several cycles of freezing and thawing. CAT assays 
were performed as described by German et al. [26]. Protein concentra- 
tion was determined by the BioRad assay. 
Luciferase activity in cell extracts was measured essentially accord- 
mg to de Wet et al. [27], using a Berthold Blolumat LB 9501 luminom- 
eter. CAT activity in the extracts of the transfected cells was notmal- 
ized to the luciferase activity. Each transfecrion experiment was re- 
peated at least four times and gave reprod~c~bI~ results. 
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2.3. RNA ~solutron and prvner extension (5) oligotSp1) [33]. 1 Imer: 5’-CGGGGCGGGGC-3’; 
SKNBE cells were seeded at a density of 1 x lo6 m a 100 mm Petri 
dish and re-fed with 10 ml of fresh medtum 4 h before transfecttons. 
32 h after transfection. cells were scraped and the total cytoplasmtc 
RNA was isolated by the phenol&chloroform method [28]. 
(6) Mutant Spl. 20mer (aldolase C): 5’-GGTCATTTCTTTCATGC- 
AGC-3’; 
Primer extenston on RNA from cells transfected with aldolase C- 
CAT chimertc plasmids was carried out as described by Ham et al. 
[29]. The elongation reacttons were performed m 20 ~1 (final volume) 
using 1 ,ul (20 U) of MMLV reverse transcrtptase (Boehrmger 
Mannheim) and 4 ~1 of the 5 x reverse transcriptase buffer The 
reaction was carried out at 42°C for 120 mm and stopped by the 
addition of 1 ~1 of 0 5 M EDTA and DNase-free RNase to 30 pg/ml: 
the RNA was digested at 37°C for 30 min. The mixture was extracted 
once with phenol/chloroform and then ethanol precipitated; the pellet 
was dissolved m formamtde loading buffer and loaded on 6% denatur- 
mg polyacrylamide gel.The gel was fixed m 10% acetic acid, dried and 
autoradtographed at -80°C with intensifying screens. 
(7) Unrelated ohgo. 20mer. 5’-GACATCCGCAGCCTCATTTA-3’. 
3. RESULTS 
2.4. Nucleur extract. DNuse I footprint and gel rrtardatton ussqs 
Nuclear protein extracts were prepared as described by Shapiro et 
al. [30]. A 184 bp long fragment, including the region from -164 to 
+20, and a fragment spanning from -269 to - 196 (f 1 being the major 
transcription start site) of the aldolase C gene promoter were used as 
probes for the binding reactions. Labeling reaction was performed 
using Klenow polymerase (Amersham) and a-(Z’P)dATP (DuPont) or 
polynucleotide kinase (Promega) and [y-“P])dATP (DuPont). Syn- 
thetic complementary oligonucleotides. used as probes or as compett- 
tors in the gel retardation and footprmt assays, were synthesized on 
an Applied Biosystem 95 1 synthesizer, purified on acrylamide gels and 
5’- end labeled using T4 polynucleotide kinase (Promega). Gel shift 
assays were performed as described elsewhere [31]. in the presence of 
3pg poly(dI/dC) per sample, as non-specific competitor. Samples were 
loaded on 5% non-denaturing polyacrylamtde gel. DNase 1 footprints 
were performed as described by Ltchtsteiner et al. [33]. 
To localize &-elements that regulate the efficiency of 
the aldolase C gene promoter, a series of 5’-deleted 
promoter fragments were fused to the CAT gene in the 
pEMBL-g-CAT vector and used in transient transfec- 
tions into the human neuroblastoma cell line (SKNBE). 
Plasmids pEMBL-&CAT wild type and pGM2-CAT 
(containing the Rous Sarcoma virus long terminal re- 
peat) were used as negative and positive control, respec- 
tively. CAT activity is thus expressed as percentage of 
the activity obtained by transfection of the pGM2-CAT 
construct that was arbitrarily assigned 100% and nor- 
malized to the luciferase activity of the extracts. 
The following double-stranded oligonucleotides here used as com- 
petitors or probes: 
(1) ohgo( 24mer (aldolase C protection A), 5’-ATGCAGCCACG- 
CCCCCGGAGGAGT-3’; 
(2) oligo(b). 30mer (aldolase C protection B). S’-GAGGGGGTGT- 
GGTCAGGGCGGGCATGCAGC-3’: 
(3) ohgo( 23mer (aldolase C protection C): 5’-GCCTCTGAGGG- 
CGTGGTCTTGCC-3’; 
(4) oligo(d). 39mer (aldolase C protection D): 5’-TAAAGGGATT- 
GTGGCAGAAATGAACGCAAGGTCATGGCC-3’: 
The fusion constructs with their relative CAT activity 
are shown in Fig. 1. Construct A-l 190, containing 1190 
bp upstream from the initiation start site [ 171, is able to 
direct the transcription of a reporter gene with an effi- 
ciency of about 65% with respect to the pGM2-CAT 
positive control. Higher activity, of about 90%, is gener- 
ated with A-820 and A-420 constucts. The reduction in 
activity seen with construct A-l 190 suggests that se- 
quences between - 1190 and -820 may contain negative 
regulatory elements or that distal sequences may form 
bent DNA that decreases the promoter activity. A de- 
crease of activity was observed with constructs A-164 
and A-86, which contain 164 bp and 86 bp, respectively. 
These data indicate the presence of important positive 
regulatory elements in the region from -420 to - 164 bp. 
However, constructs A-164 and A-86 still show 30% of 
CAT activity over the background levels of expression 
obtained with the pEMBL-8-CAT negative control. 
To determine the correct transcription start site of the 
Fig. 1. Transient expression of human aldolase C gene-CAT fusion constructs. Schematic diagram of the aldolase C 5’-flanking region. The first 
exon (black box), the start site of transcription (+l) and some restriction sites are indicated. 5’-deleted clones contam 20 bp of the first exon; relative 
CAT activity was normahzed to the pGM2-CAT construct which was arbitrarly assigned 100% activity. All extracts were adjusted to identical 
luciferase activities. 
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aldolase C-CAT fusion constructs, primer extension ex- 
periments were performed on RNA from SKNBE cells 
transfected with constructs A-420, A-164 and A-86 (Fig. 
2). The A-420 construct is able to initiate transcription 
(see Fig. 2, lane 1 thick arrow) at the major start site, 
which in the genomic sequence lies 1342 bp upstream 
from the methionine codon, previously determined on 
the endogenous RNA [17]. A displacement of the major 
start site and also of some minor sites was observed 
(thin arrows) with constructs A-164 and A-86 (lanes 2 
and 3). This indicates that the region from -420 to - 164 
bp is important not only for the enhancement of tran- 
scriptional activity of the promoter, but also for the 
precise and specific start of transcription. 
DNase I digestion of a 184 bp fragment, spanning 
from -164 to +20, in the presence of SKNBE nuclear 
extracts revealed three protected elements, A, B and C 
(Fig. 3). Element A spans from -37 to -54 bp relative 
to the major start site. This is a GC-rich region and 
contains a C stretch that has been found to be the 
recognition site for the trans-acting factor ETF [34]. 
Element B (from -56 bp to -82 bp) contains the consen- 
sus core sequence for the ubiquitous trans-acting factor 
Spl [35] and a sequence similar to the AP3 consensus 
sequence [36]. Since only two nucleotides divide ele- 
ments A and B, it may be considered one large protected 
segment. Element C, which shows a protection that cov- 
ers the sequence between -103/-114 bp, appears not 
crucial either for the transcriptional activity or for the 
correct initiation of transcription (compare in Figs. 1 
and 2, the CAT activity and the initiation of transcrip- 
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Fig. 2. Primer extension analysis. 50 pg of total cytoplasmic RNA 
from SKNBE cells transfected with the chimeric constructs and with 
the positive control plasmid pGM2-CAT were used for primer exten- 
sion analysis. Elongated products corresponding to the correct mitia- 
tion start site of the human aldolase C gene chimeric constructs (lanes 
1 to 3) are indicated by a thick arrow. Thin arrows indicate a displace- 
ment of the major start site obtained with constructs 4-164 and 4-86 
(lanes 2 and 3). Size markers were obtained by sequencmg A-420 DNA 
annealed to the same primer used for the extension reaction. 
? Lower 5 
Upper 
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Fig. 3. DNase I protectton analysis of the aldolase C promoter region. 
The human aldolase C gene promoter, from -164 to +20 bp, lower 
and upper strand, were end-labeled and incubated on ice with (lanes 
3.4 and 5) or without (lanes 1 and 2) 20 pg of SKNBE nuclear extract 
for 90 min. The DNA was digested with 50 ng of DNase I for 1 min 
and 2 min (lanes 1 and 2, respectively) or 200 ng for 1 min. 2 min and 
3 min (lanes 3, 4 and 5. respectively) and the products were analyzed 
on 6% sequencing gel. Maxam-Gtlbert sequencing reactions obtained 
from the same fragment were used as markers. The position and the 
sequences of the protected regions are schematically depicted. An 
arrow indtcates a DNase I hypersensitivity sue 
tion using constructs A-164 and A-86). To analyze the 
tvans-acting factors involved in the binding to elements 
A and B, we performed a footprinting competition anal- 
ysis using 50- and lOO-fold molar excesses of the ol- 
igonucleotide for Spl. This oligonucleotide was able to 
remove both protection A and B (see Fig. 4, lanes 5 and 
6). No competition with protections A and B was ob- 
served using a mutated Spl consensus sequence or an 
unrelated oligonucleotide as competitor (Fig. 4, lanes 
7-10). These results indicate that Spl and/or similar 
factors may bind to the GC-rich A and B elements. 
Since element B contains a consensus sequence for AP3, 
we used a lOO-fold molar excess of an oligonucleotide 
containing the homologous AP3 sequence as competi- 
tor. Under our conditions we were not able to detect any 
competition (data not shown). 
The -420 to - 164 region that appeared important for 
the enhanced transcriptional activity of clones A-820 
and A-420 was analyzed by DNase I digestion assay. No 
DNase I protected sequences were observed between 
sequences from -420 to -269. Using as probe a frag- 
ment from -269 to -164 (Fig. 5. panel A), a protected 
element from -203 to -196 (element D) was mapped. 
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Fig. 4. DNase I footprinting competition analysts. The lower strand 
of the aldolase C promoter (- 164 to +20) was end-labeled and incu- 
bated on tee wtth (lanes from 3 to 10) or without (lanes 1 and 3) 2Opg 
of SKNBE nuclear extract for 90 min on ice. DNase I dtgesttons were 
carried out on tee usmg 50ng of the enzyme for I min, 2 mm (lanes 
land 2) or 200 ng for 2 min (lanes 3-10). Unlabeled competitors at 50- 
and lOO-fold molar excesses were used: ohgo Spl (lanes 5 and 6). 
mutant Spl (lanes 7 and 8) or unrelated obgonucleottde (lanes 9 and 
10). The protected areas are schematically deptcted An arrow mdi- 
cates a DNase I hypersensttivny sate 
Gel mobility assays, using labeled oligonucleotides. 
encompassing the protected regions A and B of Fig. 3, 
show two major retarded bands for each oligonucleo- 
tide (Fig. 6, lanes 1 and 6). Competition with a 50-fold 
molar excess of cold oligonucleotide for Spl is able to 
displace both DNA-protein complexes formed with ele- 
ments A and B (lanes 3 and 9). Using an oligonucleotide 
containing a mutated sequence for Spl (lane 8) or an 
unrelated oligonucleotide (lanes 4 and IO), the bands 
were not competed. These data strongly suggest that 
Spl or a factor with the same sequence specificity is 
involved in the binding to elements A and B. The oli- 
gonucleotide that includes protection C of Fig. 3 also 
gives rise to two major DNA-protein complexes (Fig. 
6, lane 12). The specificity of the binding was assessed 
by competing the bandshift with itself or with unrelated 
oligonucleotides. Binding was competed by 25- and 50- 
fold molar excesses of the same unlabeled oligonucleo- 
tide (lanes 13 and 14). Although also this element is 
GC-rich, no competition was observed using a 50-fold 
molar excess of the Spl oligonucleotide (lane 15) or of 
an unrelated oligonucleotide (lane 16). Gel shift analysis 
of the region activating the transcription indicates that 
the oligonucleotide d from -230 to - 190 bp displays a 
specific bandshift (see Fig. 5, panel B lane 1) that is 
removed using a 50-fold molar excess of the same cold 
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oligonucleotide (lane 2). No competition was observed 
using the same molar excess of the oligonucleotide con- 
taining the Spl binding site or an unrelated oligonucleo- 
tide (lanes 3 and 4). The -230 to - 190 region is included 
in clones A-l 190, A-820 and A-420. all of which show 
enhanced activity, and excluded from clones A- 164 and 
A-86, which show a decreased activity. Therefore, the 
binding of a protein to the -230 to -190 sequences 
strongly indicates that an activating DNA element. des- 
ignated ‘element D’ (Fig. 5), is responsible for the full 
activity of the promoter. 
4. DISCUSSION 
The 5’-flanking region of the brain-specific aldolase 
C gene possesses unusual features for a tissue-specific 
gene. In fact, it is characterized by an AT-rich region 
and a 68% GC-rich region respectively localized -700 
bp and -228 bp upstream from the major transcription 
start site. A canonical CAAT box is found at nucleotide 
-736; however this is not the expected position of a 
functional CAAT box relative to the transcription start 
site [17]. 
In this study we have shown that the 5’-flanking se- 
quences of the human aldolase C gene, function as a 
stronger promoter in human neuroblastoma cells. We 
have identified DNA segments that contain c&acting 
elements, localized from -54 to -37 (A), -82 to -56 (B) 
and -114 to - 103 (C) from the major transcription start 
site, respectively. Furthermore, an upstream segment 
(element D) spanning from -203 to -196. which we 
describe as a second region essential for transcription. 
has been found to be a strong activating element for the 
promotion of transcription. 
Experiments presented in this paper suggest that Spl 
or Spl-like factors may be involved in the binding to 
element B, where a consensus sequence for Spl is local- 
ized. Also element A, although lacking the canonical 
Spl consensus sequence, seems to interact with factors 
that bind to GC-stretches. A number of studies have 
established that Spl activates promoters of various cel- 
lular genes, including mouse dihydrofolate reductase 
[37], mouse adenine phosphoribosyl-transferase [38], 
human c-Ha-ras [39], human adenosine deaminase [40], 
human ~120 antigen [41], human amyloid precursor 
protein [42], human DIA dopamine receptor [43], 
human neuropeptide Y [44], human Pim-1 proto-onco- 
gene [45], human and rat CI subunit of the regulatory 
protein GO [46] and human nerve growth factor recep- 
tor gene [47]. 
Like aldolase C, these genes belong to the so-called 
‘TATA-less promoters’ and are characterized by ex- 
tremely GC-rich regions. Some of them are considered 
housekeeping genes and are expressed in most cell 
types, others are tissue-specific genes like aldolase C. 
The role of Spl in the regulation of such a diverse 
composite set of genes is still unknown, but probably 
Volume 328, number 3 FEBS LETTERS August 1993 
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Fig. 5. DNase I footprinting and gel mobility shift analyses. A: The lower strand of aldolase C promoter (from -269 to -164) was end-labeled 
and incubated 90 min on ice wtth (lanes 4,5 and 6) or without (lanes 1,2 and 3) 2Opg of SKNBE nuclear extract. Samples were subsequently digested 
with 50 ng of DNase I for 1 min, 2 mm and 3 min on ice (lanes 1. 2 and 3) or wrth 200 ng of the enzyme for 1 mm, 2 mm and 3 min (lanes 4. 
5 and 6). The protected region is schematically depicted. B: Gel mobility shift analysts of the protected area D. Labeled oligonucleotide d (from 
-230 to -190) was incubated with 4 pg of SKNBE nuclear extract. Competttors were added to the reaction at a 50-fold molar excess, prior to 
the addition of the extract. The oligonucleotides used are listed above each lane. Arrows Indicate the specific retarded bands. 
requires interaction with other promoter elements, 
some of which might be tissue-specific. In addition, mul- 
tiple factors that, besides factor Spl, recognize GC 
boxes have been found. These include the transcription 
factor ETF, that stimulates in vitro the transcription 
from several promoters without TATA boxes [34], and 
the brain-derived GC-box-binding factor, present in 
brain extracts and absent from liver and kidney ex- 
tracts, that regulates the transcription of the murine 
brain tissue plasminogen activator (t-PA) [48]. Further 
experiments using deletion or mutation of the Spl bind- 
ing sites detected in the -82 to -37 region are required 
to assess the role of these GC-rich elements in the regu- 
lation of the aldolase C promoter. 
The biological significance of element C is not yet 
clear. The deletion of this area, in fact, does not signif- 
Fig. 6. Gel mobility shift analysis of protected areas A (lanes 1 to 5). (B) (lanes 6 to 11) and (C) (lanes 12 to 17). Reactions were performed using 
4pg of SKNBE nuclear extracts and labeled oligonucleotides a, b and c encompassing the three protectrons, respectively. Competitors, used at a 
50-fold molar excess, are listed above each lane (see also Matertals and Methods). Unlabeled ohgonucleotide c was used at 25-fold and 50-fold 
molar excess m lanes 13 and 14, respectively. Arrows indicate the specific DNA-protein complexes observed. 
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icantly affect CAT activity (see Fig. 1, constructs A- 164 
and A-86). Experiments using point mutant clones 
should clarify its contribution to the transcriptional reg- 
ulation of this gene. 
The second region, which maps from -420 to -164, 
appears to confer full activity to the promoter (compare 
A-420 and A-164 in Fig. 1). This region. as shown by 
primer extension experiments, also seems to be impor- 
tant for the correct positioning of the transcription initi- 
ation site (compare clones A-420 and A-164 in Fig. 2). 
Clone A-164, which lacks this element, shows not only 
a decrease of CAT activity, but also a displacement of 
the major start site of transcription. 
DNase I footprint and gel shift experiments enabled 
us to identify a protected area (called ‘element D’) map- 
ping from -203 to -196 (Fig. 5, panels A and B). This 
element contains half the palindromic motif. identified 
as a functional estrogen responsive element (ERE) 
[49,50]. Whether this element might also affect the tran- 
scription of the aldolase C gene remains to be proved. 
Taken together, the expression of the human aldolase 
C gene seems to be due to interactions of several factors, 
including the ubiquitous Sp 1 or Sp 1 -like factors, and an 
upstream activator (element D). Since we found low 
levels of aldolase C mRNA in non-nerve cell lines, such 
as human hepatoma cells (Hep3B). human fibroblasts, 
HeLa cells and human lymphocytes (data not shown), 
the prevalence of aldolase C transcripts in neuronal 
tissues may also be due to both transcriptional and 
post-transcriptional events such as different messenger 
stabilization in different tissues. In addition, post-trans- 
lational modifications could account for the efficient 
transcriptional regulation of tissue-specific genes. In 
this respect, the Spl factor has been shown to be post- 
translationally modified by O-glycosylation and this 
modification has been demonstrated to be relevant for 
its transcriptional activity [51]. However, other hypoth- 
eses. including different chromatin structures that in 
vivo could restrict to specific tissues the binding of tran- 
scriptional factors to DNA or the presence of distant 
control elements outside the 1.2 kb region characterized 
so far, cannot be excluded. 
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